PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PetMed Express, Inc.

Petmed Express ( ($PETS) ) has provided an update. On September 17, 2026, PetMed Express expanded its board to five directors by appointing human c...

PetMed Express adds human capital expert to board

Pets at Home ( ($GB:PETS) ) has shared an announcement. Pets at Home Group plc has granted Chief Executive Officer James Bailey a performance share...

Pets at Home grants CEO major performance-based share award

Pets at Home ( ($GB:PETS) ) has shared an announcement. Pets at Home Group plc has granted a performance share award to its chief financial officer...

Pets at Home grants major performance share award to CFO

Shore Capital analyst initiated coverage with a Buy rating on Pets at Home today and set a price target of p265.00. The word on The Street in gener...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PETS	$1.57	-0.32%	60.23K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PETS	$1.57	-0.3%	60.23K
3
4
5
6

PETS

Get PetMed Express, Inc. Data in Excel

Get PetMed Express, Inc. Data in Excel